Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Sean Mcclain Biography and Net Worth

Insider of Absci

Mr. McClain is our Founder and has served as our Chief Executive Officer since August 2011 and a member of our board of directors since the formation of Absci Corporation in October 2020, and a managing member of its predecessor, AbSci LLC, since inception. Mr. McClain also serves as a board member for the Oregon Bioscience Association, Oregon Bioscience Incubator and Oregon Translational Research and Development Institute (OTRADI), and Life Science Washington. Mr. McClain holds a Bachelor of Science degree in Molecular and Cellular Biology in 2011 from the University of Arizona.

What is Sean Mcclain's net worth?: The estimated net worth of Sean Mcclain is at least $17.05 million as of July 26th, 2021. Mr. Mcclain owns 6,361,800 shares of Absci stock worth more than $17,049,624 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Mcclain may own. Learn More about Sean Mcclain's net worth.
How do I contact Sean Mcclain?: The corporate mailing address for Mr. Mcclain and other Absci executives is , , . Absci can also be reached via phone at 360-949-1041 and via email at [email protected]. Learn More on Sean Mcclain's contact information.
Has Sean Mcclain been buying or selling shares of Absci?: Sean Mcclain has not been actively trading shares of Absci over the course of the past ninety days. Most recently, on Wednesday, January 19th, Sean Mcclain bought 7,155 shares of Absci stock. The stock was acquired at an average cost of $6.92 per share, with a total value of $49,512.60. Learn More on Sean Mcclain's trading history.
Who are Absci's active insiders?: Absci's insider roster includes Todd Bedrick (VP), Sarah Korman (General Counsel), Sean Mcclain (Insider), and Karen Mcginnis (Director). Learn More on Absci's active insiders.
Are insiders buying or selling shares of Absci?: In the last year, Absci insiders bought shares 1 times. They purchased a total of 222,222 shares worth more than $999,999.00. In the last year, insiders at the sold shares 2 times. They sold a total of 3,119,859 shares worth more than $13,738,897.82. The most recent insider tranaction occured on June, 13th when CFO Zachariah Jonasson sold 19,859 shares worth more than $98,897.82. Insiders at Absci own 9.8% of the company. Learn More about insider trades at Absci.
Information on this page was last updated on 6/13/2024.

Sean Mcclain Insider Trading History at Absci

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/19/2022	Buy	7,155	$6.92	$49,512.60
7/26/2021	Buy	600	$16.00	$9,600.00	6,361,800

Sean Mcclain Buying and Selling Activity at Absci

Absci Company Overview

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Today's Range

Now: $2.68

$2.55

$2.72

50 Day Range

MA: $3.86

$2.68

$4.32

2 Week Range

Now: $2.68

$1.33

$6.72

Volume

1,059,977 shs

Average Volume

1,418,663 shs

Market Capitalization

$307.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.18

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Get Your Free Gold Guide